Two case histories of severe, early onset intrauterine growth retardation are presented. Intravenous prostacyclin was administered in an attempt to promote fetal growth and thus prolong the pregnancy, but was unsuccessful and resulted in intrauterine death in each case. The possible reasons for the failure of this treatment and alternative therapeutic options are discussed.
BrosensI., DixonH.G., RobertsonW.B.Fetal growth retardation and the arteries of the placental bed.Br J Obstet Gynaecol1977; 84: 656–63
2.
KhongT.Y., De WolfF., RobertsonW.B., BrosensI.Inadequate maternal vascular response to placentation in pregnancies complicated by pre-eclampsia and by small-for-gestational age infants.Br J Obstet Gynaecol1986; 93: 1049–59
3.
YlikorkalaO., MakilaU-M. Prostacyclin and thromboxane in gynecology and obstetrics.Am J Obstet Gynecol1985; 152: 318–29
4.
GoodmanR.P., KillamA.P., BrashA.R., BranchR.A.Prostacyclin production during pregnancy: Comparison of production during normal pregnancy and pregnancy complicated by hypertension.Am J Obstet Gynecol1982; 142: 817–22
5.
RemuzziG., MarchesiB., ZojaSB.. Reduced umbilical and placental vascular prostacylin in severe pre-eclampsia.Prostaglandins1980; 20: 105–10
6.
CarrerasL.O., VermylenJ., SpitzB., Van AsscheA.‘Lupus’ anticoagulant and inhibition of prostacyclin formation in patients with repeated abortion, intrauterine growth retardation and intrauterine death.Br J Obstet Gynaecol1981; 88: 890–4
7.
LubbeW.F.Platelets, prostaglandins and recurrent fetal death.Prostaglandin Perspectives1985; 2: 1–4
8.
WallenburgH.C.S., RotmansN.Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth.Am J Obstet Gynecol1982; 144: 523–8
9.
PicklesH., O'GradyJ.Side effects occurring during administration of epoprostenol (prostacyclin, PGI2), in man.Br J Clin Pharmacol1982; 14: 177–85
10.
AnsellS., BelchJ.J.F., ForbesC.D.Depression and prostacyclin infusion.Lancet1986; ii: 509
11.
CampbellS.Fetal growth. In BeardR.W., NathanielszP.W. eds. Fetal physiology and medicine, London: Saunders, 1974: 271
12.
PearceJ.M.Uteroplacental and fetal blood flow.Clin Obstet Gynaecol1987; 1: 157–84
13.
HackettG.A., CampbellS., GamsuH., Cohen-OverbeekT., PearceJ.M.F.Doppler studies in the growth retarded fetus and prediction of neonatal necrotising enterocolitis, haemorrhage, and neonatal morbidity.Br Med J1987; 294: 13–16
LewisP.J., ShepherdG.L., RitterJ.. Prostacyclin and pre-eclampsia.Lancet1981; i: 559
16.
ElderM.G., MyattL.First use of Nafazatrom, a new antithrombotic drug, in pregnancy.Lancet1984; i: 1350
17.
VerymylenJ., ChamoneD.A.F., VerstraeteM.Stimulation of prostacyclin release from vessel wall by Bay g 6575, an antithrombotic compound.Lancet1979; i: 518–20
18.
BeaufilsM., UzanS., DonsimoniR., ColauJ.C.Prevention of pre-eclampsia by early antiplatelet therapy.Lancet1985; i: 840–2
19.
WallenburgH.C.S., DekkerG.A., MakovitzJ.W., RotmansP.Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive Primigravidae.Lancet1986; i: 1–3
20.
MoncadaS., KorbutR.Dipyridamole and other phosphodiesterase inhibitors act as antithrombotic agents by potentiating endogenous prostacyclin.Lancet1978; i: 1286–9
21.
GreerI.A.Aspirin with an adrenergic or a calcium-channel-blocking agent as new combination therapy for arterial thrombosis.Lancet1985; i: 351–2
22.
BakkateigL.S., HoffmanH.J., HarleyE.E.The tendency to repeat gestational age and birth weight in successive births.Am J Obstet Gynecol1979; 135: 1086–103
23.
CampbellS., PearceJ.M.F., HackettG., Cohen-OverbeekT., HernandezC.Qualitative assessment of uteroplacental blood flow: early screening test for high-risk pregnancies.Obstet Gynecol1986; 68: 649–53
